If BPC-157 demonstrates efficacy and safety in properly designed human trials, I would be among the first to incorporate it
The dose of vitamin B12 shots depends on how bad the deficiency is and the type of B12 used
Lipid panel: clinical trials have documented triglyceride reductions on tesamorelin
Whole blood was mixed 1:1 with 3% dextran T-500 (Pharmacosmos)/0.9% NaCl and incubated at room temperature for 20 min to sediment erythrocytes
However, BPC-157 may fall under WADAs broader categories prohibiting peptide hormones, growth factors, and related substances
July 23, 2026: Pharmacy Compounding Advisory Committee meeting The FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) meeting for July 23, 2026 to evaluate BPC-157 and TB-500 (free base and acetate forms), along with KPV and MOTs-C